Tag: Aspirin
![A decision tool (dual antiplatelet therapy [DAPT] score) improves risk prediction for continued DAPT beyond assessment of myocardial infarction history](https://www.ehealth-news.com/wp-content/uploads/2016/06/heart0331.jpeg "DAPT Score Improves Risk Prediction of Continued DAPT")
DAPT Score Improves Risk Prediction of Continued DAPT
Score improves prediction of benefit and harm for continued DAPT therapy beyond MI history alone
Major Stroke May Be Prevented by Taking Aspirin After TIA
Researchers find risk is reduced by as much as 80 percent
Ticagrelor Doesn’t Beat Aspirin in Ischemic Stroke, TIA
Ticagrelor not superior to aspirin for reducing composite of stroke, myocardial infarction, death
Regular Aspirin Use May Protect Against Bile Duct Cancer
People who took it regularly were three times less likely to develop the disease
Continued Aspirin Treatment Safe With Partial Nephrectomy
Findings among patients on chronic antiplatelet therapy for cardioprotection
Improved Survival for Certain Cancers With Low-Dose Aspirin
Improved odds seen for patients with colon, prostate, or breast tumors, but research isn't definitive
USPSTF: Aspirin Recommended for Some Aged 50 to 69 Years
Benefits for primary prevention of CVD, CRC for certain adults aged 50 to 69 years
ACC: PPI Tx Also Beneficial for Those on Low-Dose Aspirin
Gastroprotection with PPI therapy reduced primary GI end point in patients on low-dose aspirin
PA32540 Safe for Patients at Risk of Aspirin-Linked Upper GI Events
Long-term, once-daily enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg is safe
Daily Low-Dose Aspirin May Reduce Risk of Some Cancers
Effect was seen most strongly with colon, gastrointestinal tumors
